{"meta":{"query_hash":"e9ba3189121d","filters":{"venue":"Clinical Prostate Cancer"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e9ba3189121d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Prostate+Cancer"},"results":[{"id":"W2001143432","doi":"10.3816/cgc.2003.n.017","title":"Active Surveillance with Selective Delayed Intervention: A Biologically Nuanced Approach to Favorable-Risk Prostate Cancer","year":2003,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Watchful waiting; Medicine; Prostate cancer; Disease; Intervention (counseling); Internal medicine; Prostate-specific antigen; Oncology; Cancer; Intensive care medicine","score_opus":0.08358071807234146,"score_gpt":0.4218320146886531,"score_spread":0.33825129661631165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001143432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040956217,0.9982053,0.00037755398,0.00025275082,0.00011453475,0.000008308944,0.000009847966,0.000007958646,0.0006141221],"genre_scores_gemma":[0.0048749913,0.9934437,0.0005062768,0.00046347204,0.0002728443,0.000012029123,0.000027942851,0.0000021558149,0.00039648573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998274,0.000049380844,0.00002633218,0.00003914267,0.000044448378,0.000013284211],"domain_scores_gemma":[0.99971217,0.00016440109,0.00006649351,0.000008563209,0.000027824532,0.000020603955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056981825,0.00074739376,0.001757382,0.0010721771,0.00018083211,0.0005480037,0.00092790194,0.0005830653,0.0021026004],"category_scores_gemma":[0.0008496605,0.00020271348,0.00064002565,0.0008567831,0.00045124718,0.0007357025,0.00040280246,0.0014443864,0.00043235297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002091063,0.00010529206,0.0005686305,0.012967633,0.00016773521,0.00028236635,0.000037424827,0.0005189631,0.00078769954,0.0010598797,0.00861548,0.9746799],"study_design_scores_gemma":[0.0007678361,0.0023051512,0.0143869575,0.022985036,0.0032152452,0.015998753,0.00024324594,0.0010551643,0.0022089905,0.0044880114,0.9322327,0.00011289894],"about_ca_topic_score_codex":0.001265727,"about_ca_topic_score_gemma":0.0039410074,"teacher_disagreement_score":0.0021026004,"about_ca_system_score_codex":0.000518512,"about_ca_system_score_gemma":0.0009523682,"threshold_uncertainty_score":0.007033944},"labels":[],"label_agreement":null},{"id":"W2011246519","doi":"10.3816/cgc.2005.n.002","title":"Combined Androgen Blockade: The Case for Bicalutamide","year":2005,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Bicalutamide; Antiandrogen; Flutamide; Medicine; Prostate cancer; Castration; Urology; Antiandrogens; Internal medicine; Enzalutamide; Androgen; Oncology; Androgen receptor; Hazard ratio; Androgen deprivation therapy; Randomized controlled trial; Testosterone (patch); Combination therapy; Endocrinology; Cancer; Hormone; Confidence interval","score_opus":0.23588876844973317,"score_gpt":0.5315328612553668,"score_spread":0.29564409280563364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011246519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016004885,0.9981171,0.00009289961,0.00054682203,0.00016130427,0.0000023614825,0.0000075994844,0.0000058846085,0.00090599206],"genre_scores_gemma":[0.0021169032,0.9952461,0.00033572482,0.0011227621,0.00029861007,0.0000057053458,0.000019955534,0.0000035976302,0.0008506289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997093,0.000067949906,0.00005206424,0.00004966583,0.00009590821,0.000024985315],"domain_scores_gemma":[0.99948114,0.0003293326,0.00007767273,0.000016485626,0.000064889886,0.000030456875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076676643,0.0005678989,0.0023408183,0.0012982424,0.0002593622,0.0009200418,0.0012510307,0.0014438556,0.0026766327],"category_scores_gemma":[0.0011033476,0.00025147482,0.00066560117,0.0015754228,0.00060425454,0.0010982539,0.00045464278,0.002787175,0.0013571364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021362894,0.000037518566,0.00024433402,0.00928745,0.00018596566,0.0017419367,0.0000679288,0.00018178516,0.000835476,0.0023530188,0.037752643,0.9470982],"study_design_scores_gemma":[0.00015180213,0.00012153554,0.0011838451,0.0063935737,0.00038697175,0.011684917,0.00012523623,0.00011218397,0.0004406684,0.0023671617,0.97700727,0.000024800047],"about_ca_topic_score_codex":0.0016722367,"about_ca_topic_score_gemma":0.0066023543,"teacher_disagreement_score":0.0026766327,"about_ca_system_score_codex":0.000670755,"about_ca_system_score_gemma":0.0010081307,"threshold_uncertainty_score":0.008954227},"labels":[],"label_agreement":null},{"id":"W2021847075","doi":"10.1016/s1540-0352(11)70082-8","title":"Role of Magnetic Resonance Spectroscopic Imaging in the Prediction of Treatment Outcome in Prostate Cancer","year":2004,"lang":"en","type":"letter","venue":"Clinical Prostate Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Medicine; Magnetic resonance imaging; Nuclear medicine; Prostate cancer; Effective diffusion coefficient; Prostate; Standard deviation; Rectum; Flip angle; Radiology; Cancer; Internal medicine; Mathematics","score_opus":0.04778675804492902,"score_gpt":0.3836048825484688,"score_spread":0.33581812450353976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021847075","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032433696,0.02162123,0.0011909849,0.9153803,0.015463512,0.000052234438,0.00014617511,0.00009534091,0.013616588],"genre_scores_gemma":[0.39582193,0.024137635,0.0028508075,0.3642922,0.20397043,0.00015277205,0.0002382383,0.00006922982,0.008466859],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9982994,0.00088604685,0.00024537568,0.000097079384,0.00033584618,0.00013627212],"domain_scores_gemma":[0.9914619,0.006468688,0.00032893455,0.00021303598,0.0009276153,0.00059991557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00222908,0.0005513266,0.0017360002,0.00082082406,0.0010719452,0.0017181319,0.0013294796,0.012877542,0.0014177752],"category_scores_gemma":[0.02186865,0.00045824106,0.00072925416,0.00067682966,0.0014919157,0.0015748274,0.00038825686,0.010891683,0.0010562817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033171515,0.0008092651,0.15603077,0.0007840981,0.00058907643,0.06415829,0.00071125693,0.0027852242,0.0037868107,0.0064345147,0.5385209,0.22207274],"study_design_scores_gemma":[0.0026267387,0.0031555889,0.16509342,0.0025034966,0.001406073,0.14080691,0.0020669068,0.037770245,0.006862456,0.04789259,0.5892862,0.0005293565],"about_ca_topic_score_codex":0.004271034,"about_ca_topic_score_gemma":0.0071443785,"teacher_disagreement_score":0.012877542,"about_ca_system_score_codex":0.0022621749,"about_ca_system_score_gemma":0.0013195599,"threshold_uncertainty_score":0.016413331},"labels":[],"label_agreement":null},{"id":"W2030339269","doi":"10.3816/cgc.2005.n.009","title":"Clinical Benefit of Zoledronic Acid for the Prevention of Skeletal Complications in Advanced Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Prostate Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Bone pain; Internal medicine; Incidence (geometry); Placebo; Pathologic fracture; Oncology; Cancer; Surgery; Urology; Pathology","score_opus":0.07892006890509327,"score_gpt":0.4796531205865005,"score_spread":0.4007330516814072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030339269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8321381,0.15295067,0.00039619202,0.0030089105,0.00050315115,0.00019649489,0.0005201914,0.00011603409,0.010170207],"genre_scores_gemma":[0.9837558,0.014075008,0.00022954533,0.00051657605,0.00037344545,0.000018537108,0.00019117819,0.0000039533475,0.0008359451],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9997867,0.00009531799,0.000019348132,0.000018596293,0.000043631473,0.000036445657],"domain_scores_gemma":[0.9996074,0.00016699196,0.000063464046,0.000016671309,0.000032533062,0.00011291893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044615203,0.00033301517,0.0015262092,0.00049174763,0.00025358805,0.00039723527,0.00027244433,0.00065838645,0.002607955],"category_scores_gemma":[0.0013703743,0.00014297261,0.0007900112,0.00039128773,0.0003262432,0.00021998525,0.00015361322,0.0008797098,0.00020403186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5459672,0.0038541208,0.012331696,0.0023905975,0.0021617194,0.00085156015,0.000093075796,0.0018929216,0.019654892,0.00097491225,0.003718829,0.40610853],"study_design_scores_gemma":[0.2389746,0.26611054,0.43914723,0.0005876469,0.010088079,0.003203403,0.00024397031,0.0029551352,0.01078554,0.002647675,0.025114281,0.00014195972],"about_ca_topic_score_codex":0.0019454483,"about_ca_topic_score_gemma":0.004066762,"teacher_disagreement_score":0.002607955,"about_ca_system_score_codex":0.0003583538,"about_ca_system_score_gemma":0.0006786828,"threshold_uncertainty_score":0.008724451},"labels":[],"label_agreement":null},{"id":"W2086066681","doi":"10.3816/cgc.2002.n.016","title":"Zoledronic Acid Significantly Reduces Pathologic Fractures in Patients with Advanced-Stage Prostate Cancer Metastatic to Bone","year":2002,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Osteonecrosis of the jaw; Bisphosphonate; Bone pain; Internal medicine; Cancer; Oncology; Osteoporosis; Surgery; Urology","score_opus":0.08720358540906437,"score_gpt":0.45070005960781934,"score_spread":0.36349647419875497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086066681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00304875,0.9957558,0.0001187535,0.00017062237,0.00009357426,0.00001592753,0.000101214275,0.000013128332,0.0006822832],"genre_scores_gemma":[0.021152243,0.97689533,0.00041208582,0.00048786285,0.00012923048,0.000017509237,0.00016885383,0.0000024320357,0.00073445914],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998908,0.000022421018,0.000021384047,0.000016888029,0.000039271574,0.000009331126],"domain_scores_gemma":[0.9998604,0.00007095759,0.00003463752,0.0000033511424,0.000022073586,0.000008477206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026484646,0.00045305007,0.0019832775,0.00085218495,0.00011954874,0.00028897016,0.00055912574,0.00039249277,0.002256406],"category_scores_gemma":[0.00056630647,0.00014809032,0.000706782,0.001109725,0.00013965352,0.00017172867,0.00013506706,0.0004418584,0.00032972934],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022559133,0.00016353616,0.0015955562,0.027645156,0.0017011947,0.0002473291,0.000048507256,0.00038114563,0.0024084093,0.00029151526,0.009772923,0.9534888],"study_design_scores_gemma":[0.011646406,0.013459718,0.12177259,0.015572463,0.024295095,0.011213346,0.00043369283,0.0010664413,0.007545636,0.0022209997,0.7906214,0.00015207494],"about_ca_topic_score_codex":0.0026248742,"about_ca_topic_score_gemma":0.009462725,"teacher_disagreement_score":0.0026248742,"about_ca_system_score_codex":0.00026309406,"about_ca_system_score_gemma":0.00056331925,"threshold_uncertainty_score":0.007548392},"labels":[],"label_agreement":null},{"id":"W2142606098","doi":"10.3816/cgc.2003.n.018","title":"Salvage Cryosurgery for Recurrent Prostate Cancer After Radiation Therapy: A Seven-Year Follow-up","year":2003,"lang":"en","type":"article","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cryosurgery; Prostate cancer; Radiation therapy; Cryoablation; Prostate; Urology; Prostate-specific antigen; Cancer; Surgery; Internal medicine","score_opus":0.05578848116549954,"score_gpt":0.3793201374604634,"score_spread":0.32353165629496383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142606098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965155,0.0009523713,0.00027184363,0.0001200288,0.000028386467,0.00003345196,0.0003765737,0.000024062005,0.0016776865],"genre_scores_gemma":[0.9972326,0.00027445596,0.00010612447,0.00011027235,0.00002607335,0.0000201871,0.0008538225,0.000005971964,0.0013706175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993937,0.00006431521,0.00005633272,0.00008839801,0.00013024881,0.0002670206],"domain_scores_gemma":[0.99860543,0.00023403406,0.00027142806,0.00016357699,0.00040479226,0.00032080832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076008803,0.0005500608,0.0011236672,0.0017796567,0.0014546945,0.0008153621,0.00070035533,0.0009448062,0.0012500094],"category_scores_gemma":[0.0016300568,0.00019934044,0.0016156704,0.0009025679,0.0006504398,0.0008413001,0.0007340624,0.00096754346,0.0006737374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040523927,0.0029198076,0.8980152,0.000089504814,0.00040454615,0.019175027,0.002557308,0.0007374813,0.0034925565,0.0001289773,0.0012719228,0.06715524],"study_design_scores_gemma":[0.00010196395,0.0067359335,0.9753449,0.00003892383,0.0004901503,0.011175911,0.0013011623,0.00053835224,0.0020174363,0.00016947715,0.0020000823,0.000085655585],"about_ca_topic_score_codex":0.007014306,"about_ca_topic_score_gemma":0.005206134,"teacher_disagreement_score":0.007014306,"about_ca_system_score_codex":0.0007904035,"about_ca_system_score_gemma":0.00058363465,"threshold_uncertainty_score":0.01394695},"labels":[],"label_agreement":null}]}